Logo image of SUP

SUPERIOR INDUSTRIES INTL (SUP) Stock Fundamental Analysis

NYSE:SUP - New York Stock Exchange, Inc. - US8681681057 - Common Stock - Currency: USD

2.26  -0.07 (-3%)

After market: 2.21 -0.05 (-2.21%)

Fundamental Rating

1

SUP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 81 industry peers in the Automobile Components industry. SUP may be in some trouble as it scores bad on both profitability and health. SUP does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

SUP had negative earnings in the past year.
SUP had a positive operating cash flow in the past year.
SUP had negative earnings in 4 of the past 5 years.
Each year in the past 5 years SUP had a positive operating cash flow.
SUP Yearly Net Income VS EBIT VS OCF VS FCFSUP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -16.46%, SUP is doing worse than 87.65% of the companies in the same industry.
SUP's Return On Equity of -994.50% is on the low side compared to the rest of the industry. SUP is outperformed by 93.83% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.25%, SUP is doing worse than 77.78% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SUP is below the industry average of 8.88%.
Industry RankSector Rank
ROA -16.46%
ROE -994.5%
ROIC 4.25%
ROA(3y)-9.74%
ROA(5y)-11.39%
ROE(3y)-358.5%
ROE(5y)-254.71%
ROIC(3y)5.56%
ROIC(5y)4.64%
SUP Yearly ROA, ROE, ROICSUP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

SUP has a Operating Margin of 2.31%. This is amonst the worse of the industry: SUP underperforms 80.25% of its industry peers.
SUP's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 8.72%, SUP is not doing good in the industry: 87.65% of the companies in the same industry are doing better.
SUP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.31%
PM (TTM) N/A
GM 8.72%
OM growth 3Y-16.75%
OM growth 5Y-12.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y0.61%
SUP Yearly Profit, Operating, Gross MarginsSUP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SUP is destroying value.
Compared to 1 year ago, SUP has more shares outstanding
The number of shares outstanding for SUP has been increased compared to 5 years ago.
The debt/assets ratio for SUP is higher compared to a year ago.
SUP Yearly Shares OutstandingSUP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SUP Yearly Total Debt VS Total AssetsSUP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

SUP has an Altman-Z score of 1.51. This is a bad value and indicates that SUP is not financially healthy and even has some risk of bankruptcy.
SUP's Altman-Z score of 1.51 is on the low side compared to the rest of the industry. SUP is outperformed by 83.95% of its industry peers.
A Debt/Equity ratio of 39.31 is on the high side and indicates that SUP has dependencies on debt financing.
The Debt to Equity ratio of SUP (39.31) is worse than 93.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 39.31
Debt/FCF N/A
Altman-Z 1.51
ROIC/WACC0.44
WACC9.74%
SUP Yearly LT Debt VS Equity VS FCFSUP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

SUP has a Current Ratio of 1.58. This is a normal value and indicates that SUP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.58, SUP is doing worse than 80.25% of the companies in the same industry.
SUP has a Quick Ratio of 1.58. This is a bad value and indicates that SUP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SUP (0.83) is worse than 85.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.83
SUP Yearly Current Assets VS Current LiabilitesSUP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SUP have decreased strongly by -152.07% in the last year.
The Revenue has decreased by -8.52% in the past year.
Measured over the past years, SUP shows a decrease in Revenue. The Revenue has been decreasing by -1.58% on average per year.
EPS 1Y (TTM)-152.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-257.14%
Revenue 1Y (TTM)-8.52%
Revenue growth 3Y-2.91%
Revenue growth 5Y-1.58%
Sales Q2Q%0.55%

3.2 Future

SUP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.84% yearly.
SUP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.16% yearly.
EPS Next Y77.48%
EPS Next 2Y41.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.69%
Revenue Next 2Y2.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SUP Yearly Revenue VS EstimatesSUP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
SUP Yearly EPS VS EstimatesSUP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SUP. In the last year negative earnings were reported.
Also next year SUP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SUP Price Earnings VS Forward Price EarningsSUP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

SUP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SUP is cheaper than 62.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.48
SUP Per share dataSUP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

SUP's earnings are expected to grow with 41.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.84%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SUP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUPERIOR INDUSTRIES INTL

NYSE:SUP (4/21/2025, 2:39:08 PM)

After market: 2.21 -0.05 (-2.21%)

2.26

-0.07 (-3%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)03-06 2025-03-06/bmo
Earnings (Next)04-30 2025-04-30
Inst Owners16.16%
Inst Owner Change0.21%
Ins Owners10.11%
Ins Owner Change4.35%
Market Cap67.23M
Analysts80
Price Target6.12 (170.8%)
Short Float %0.62%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.12
Dividend Growth(5Y)-33.21%
DP-2.8%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-350.04%
Min EPS beat(2)-718.48%
Max EPS beat(2)18.4%
EPS beat(4)1
Avg EPS beat(4)-207.17%
Min EPS beat(4)-718.48%
Max EPS beat(4)18.4%
EPS beat(8)1
Avg EPS beat(8)-447.01%
EPS beat(12)2
Avg EPS beat(12)-309.62%
EPS beat(16)4
Avg EPS beat(16)-239.92%
Revenue beat(2)0
Avg Revenue beat(2)-6.65%
Min Revenue beat(2)-7.74%
Max Revenue beat(2)-5.56%
Revenue beat(4)0
Avg Revenue beat(4)-8.98%
Min Revenue beat(4)-12.53%
Max Revenue beat(4)-5.56%
Revenue beat(8)0
Avg Revenue beat(8)-10.66%
Revenue beat(12)2
Avg Revenue beat(12)-8.3%
Revenue beat(16)5
Avg Revenue beat(16)-4.01%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.24%
EPS NY rev (1m)-13.1%
EPS NY rev (3m)-13.1%
Revenue NQ rev (1m)-2.3%
Revenue NQ rev (3m)-12.98%
Revenue NY rev (1m)-7.87%
Revenue NY rev (3m)-8.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF 3.67
P/B 5.49
P/tB N/A
EV/EBITDA 4.48
EPS(TTM)-4.26
EYN/A
EPS(NY)-0.96
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)0.62
OCFY27.24%
SpS42.6
BVpS0.41
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.46%
ROE -994.5%
ROCE 5.38%
ROIC 4.25%
ROICexc 4.58%
ROICexgc 4.7%
OM 2.31%
PM (TTM) N/A
GM 8.72%
FCFM N/A
ROA(3y)-9.74%
ROA(5y)-11.39%
ROE(3y)-358.5%
ROE(5y)-254.71%
ROIC(3y)5.56%
ROIC(5y)4.64%
ROICexc(3y)6.99%
ROICexc(5y)5.72%
ROICexgc(3y)7.44%
ROICexgc(5y)6.19%
ROCE(3y)7.03%
ROCE(5y)5.87%
ROICexcg growth 3Y-12.12%
ROICexcg growth 5Y-7.45%
ROICexc growth 3Y-9.45%
ROICexc growth 5Y-0.86%
OM growth 3Y-16.75%
OM growth 5Y-12.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y0.61%
F-Score3
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity 39.31
Debt/FCF N/A
Debt/EBITDA 4.16
Cap/Depr 32.73%
Cap/Sales 2.23%
Interest Coverage 0.47
Cash Conversion 15.83%
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 0.83
Altman-Z 1.51
F-Score3
WACC9.74%
ROIC/WACC0.44
Cap/Depr(3y)46.57%
Cap/Depr(5y)49.98%
Cap/Sales(3y)2.9%
Cap/Sales(5y)3.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-152.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-257.14%
EPS Next Y77.48%
EPS Next 2Y41.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.52%
Revenue growth 3Y-2.91%
Revenue growth 5Y-1.58%
Sales Q2Q%0.55%
Revenue Next Year0.69%
Revenue Next 2Y2.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.81%
EBIT growth 3Y-19.17%
EBIT growth 5Y-14.28%
EBIT Next Year221.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-142.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.58%
OCF growth 3Y-25.84%
OCF growth 5Y-35.4%